Glow Blend 70mg - (BPC-157 10mg | TB500 10mg | GHK-Cu 50mg)

GLOW Peptide Blend — 

70 mg Research Vial 

Composition: GHK-Cu 50 mg • BPC-157 10 mg • TB-500 (Thymosin-β4 fragment) 10 mg

Format: Lyophilised powder • RUO (Research Use Only)

Also known as / identifiers

• GHK-Cu (glycyl-L-histidyl-L-lysine•copper, “copper peptide”)
  Sequence: H-Gly-His-Lys-OH • CAS: 89030-95-5
• BPC-157 (Body Protection Compound-157; PL 14736)
  Sequence: H-Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val-OH • CAS: 137525-51-0
• TB-500 (Thymosin Beta-4 fragment; ACTN-sequestering peptide)
  Fragment of Tβ4; commonly supplied as TB-500 for research • CAS (Tβ4): 77591-33-4

Specifications

• Total fill: 70 mg lyophilised blend (GHK-Cu 50 mg, BPC-157 10 mg, TB-500 10 mg)
• Appearance: white to off-white lyophilised cake
• Purity: ≥ 99% (HPLC profile) • Identity: MS-confirmed
• Additives: none (no mannitol or carriers)

Recommended reconstitution (lab guidance)

• Solvent: sterile bacteriostatic water (0.9% benzyl alcohol) or suitable aqueous buffer for in-vitro work.
• Gently add solvent down the vial wall; avoid vigorous shaking.
• Storage (unopened): −20 °C. After reconstitution: aliquot, store 2–8 °C for short-term or −20 °C for extended research use. Avoid repeated freeze–thaw.

Notes for researchers

• Pickart L. et al. Work on GHK-Cu in dermal remodeling, collagen synthesis, and gene-expression modulation.
• Frank S. et al.; Malinda K. et al. Thymosin-β4/TB-500 promoting angiogenesis and wound repair via actin dynamics and VEGF/eNOS pathways.
• Sikiric P. et al.; Chang C.H. et al. BPC-157 studies on angiogenesis, cytoprotection, and tendon/ligament healing in rodent models.

Strictly for Research use only. Not for human consumption.